PD Dr. Dorota Lubgan



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells (2022) Poczta A, Krzeczynski P, Ionov M, Rogalska A, Gaipl U, Marczak A, Lubgan D Journal article Permanent LDR prostate brachytherapy: Comprehensive characterization of seed-dynamics within the prostate on a seed-only level (2022) Karius A, Lotter M, Kreppner S, Schaller V, Lubgan D, Grigo J, Fietkau R, et al. Journal article Automatisation of catheter reconstruction in interstitial breast BT using electromagnetic tracking (2022) Dürrbeck C, Abu-Hossin N, Lotter M, Kreppner S, Lubgan D, Fietkau R, Strnad V, Bert C Conference contribution Low-dose-rate Prostate Brachytherapy: Characterization of Seeds Dynamics within the Prostate (2022) Karius A, Lotter M, Kreppner S, Lubgan D, Grigo J, Fietkau R, Strnad V, Bert C Conference contribution 12 x 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma? (2021) Lubgan D, Semrau S, Lambrecht U, Gaipl U, Fietkau R Journal article 12 x 6 Gy stereotactic radiotherapy for lung tumours. Is there a difference in response between lung metastases and primary bronchial carcinoma? (2021) Lubgan D, Semrau S, Lambrecht U, Gaipl U, Fietkau R Conference contribution Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial (2020) Multhoff G, Seier S, Stangl S, Sievert W, Shevtsov M, Werner C, Pockley AG, et al. Journal article Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial (2020) Fietkau R, Hecht M, Hofner B, Lubgan D, Iro H, Gefeller O, Rödel C, et al. Journal article R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial (2020) Fietkau R, Grützmann R, Wittel UA, Croner RS, Jacobasch L, Neumann UP, Reinacher-Schick A, et al. Journal article Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial (2019) Wittel UA, Lubgan D, Ghadimi M, Belyaev O, Uhl W, Bechstein WO, Grützmann R, et al. Journal article
1 2 3